'Rheumatic disease' diaporamas de présentation

Squamous cell carcinoma

Squamous cell carcinoma. Note keratin pearls and desmosomes Name some characteristics. Only in smokers Centrally located Hypercalcemia ? PTH like substance is made CLUBBING. asthma. Note the thickened BM and SM cells. Bronchoalveolar Carcinoma. Subset of adenocarcinoma

1.15k views • 92 slides

RHEUMATIC DISEASE LABORATORY TESTING

RHEUMATIC DISEASE LABORATORY TESTING. Pitfalls: Misdiagnosis Permanent labeling of patient Needless additional testing Inappropriate therapy and/or referral Expense Overlooking the correct diagnosis NEEDLESS ANXIETY FOR PATIENT!!!. Intent: Establish a diagnosis Determine prognosis

758 views • 58 slides

MITRAL REGURGITATION

MITRAL REGURGITATION. DIPIN.S ( J.R.- MEDICINE). anatomy. The mitral valve apparatus consists of the anterior and the posterior leaflets , the mitral annulus (fixed and dynamic) The chordae tendinae Papillary muscles Underlying myocardium. Flail MV. The major causes include

998 views • 47 slides

ANA Testing

ANA Testing. Carrie Marshall 1/18/08. History. This is often-mentioned, never-seen LE cell. These dead nuclei are being engulfed by PMNs. ANA Testing. Guideline #1 Test for autoantibodies only when a consistent clinical suspicion of rheumatic disease is present.

379 views • 36 slides

ANA Testing

ANA Testing. BY ABDULLAH RADWAN. History. This is often-mentioned, never-seen LE cell. These dead nuclei are being engulfed by PMNs. ANA Testing. Guideline #1 Test for autoantibodies only when a consistent clinical suspicion of rheumatic disease is present.

390 views • 36 slides

Dermatomyositis: Muscle Histology

Dermatomyositis: Muscle Histology. Perifascicular atrophy and inflammation. Dermatomyositis Muscle Histology. Perifascicular atrophy. Vascular Hypothesis: Complement-mediated microangiopathy Deposition of complement (MAC) and antibody Reduced muscle capillaries Ischemic damage to muscle

2.55k views • 26 slides

B-CELL SUBSETS DIFFERENCES IN INFLAMMATORY RHEUMATIC DISEASES

232 views • 22 slides

Figure 3 Models of i NKT cell activation in response to endogenous antigens

Figure 3 Models of i NKT cell activation in response to endogenous antigens. Drennan, M. B. et al. (2010) Invariant natural killer T cells in rheumatic disease: a joint dilemma Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2009.261.

144 views • 1 slides

Figure 1 Development of i NKT cells in mice

Figure 1 Development of i NKT cells in mice. Drennan, M. B. et al. (2010) Invariant natural killer T cells in rheumatic disease: a joint dilemma Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2009.261.

124 views • 1 slides

Figure 2 Models of i NKT cell activation in response to exogenous antigens

Figure 2 Models of i NKT cell activation in response to exogenous antigens. Drennan, M. B. et al. (2010) Invariant natural killer T cells in rheumatic disease: a joint dilemma Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2009.261.

104 views • 1 slides